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Abstract
Liver lipid changes inmale BALB-c nude mice due to subcutaneously implanted human prostate metastatic grade IV
adenocarcinoma was studied. The prostate cancer cells were cultured in F12 plus 7.5% horse serum and 25% fetal calf
serum medium. When they reached confluence, some of these cells were fixed with glutaraldehyde and thoroughly
washed with buffer then 4 x107 cells were implanted into four mice. Four more mice were implanted with 4 x 106 viable,
unfixed cells. Four uninjected mice served as controls. All the mice were sacrificed 18 days later. The total liver lipids
(TLL) from each liver were extracted with chloroformrmethanol and dried in separate vials under a stream of gaseous
nitrogen. While being dried, the TLLof each liver sample were weighed intermittently until their weight remained con-
stant. The weight of TLLineach vial was then divided by the wet weight of each corresponding extracted liver.This was
done to normalize the liver lipids in terms of one gram of liver because livers of different wet weights were extracted. The
TLLper gram of wet liver were similar in the control and livers ofmice injected with viable cancerous cells and decreased
in the livers of mice injected with glutaraldehyde-fixed cells. When the total lipids were fractionated into polar and non-
polar lipids on silicic gels, entirely different changes were seen. The TLLof the mice injected with untreated viable cancer
cells and those injected with glutaraldehyde-fixed cells were similar while the control liver lipids classes were significantly
different. There was a decrease in the percentage of neutral lipids and an increase in the polar fractions inthe two groups
of mice injected with either cells. The growth of the viable injected prostate cells did not cause any unique lipidchanges
in these two lipidclass profiles. However, the triglycerides and total cholesterol showed wide variations among the livers
of mice injected with viable cancer cells. The ratio of the polar/neutral lipids did not differ between the mice injected
witheither cells. Thus, the present study does not support the accepted explanation that the rapidly growing cancer cells
are mainly responsible for the lipidchanges seen in animals implanted with other types of tumor cells.
Introduction
The idea that a growing tumor may influence metabo-
lism in tissues remote from its site is a fascinating one
since it implies the existence of a humoral agent that
could possibly be intercepted to study and control tumor
growth. Indeed, several investigators have obtained evi-
dence that the turnover of liver lipids is profoundly
changed in animals bearing a variety of tumors (Weber
and Cantero, 1959; Stein et al., 1965; Stein et al., 1966;
Wood, 1975; Ruggieri et al., 1976; Redgrave et al., 1984).
These altered turnover rates are reflected in the composi-
tion of the liver lipids and may indeed reveal a major
source of substrate and energy for tumor growth.
Stein and his co-workers (1965, 1966) considered that
the adipose tissue may be the ultimate source of triglyc-
eride fatty acids for this purpose, since ithas been
observed in many studies that this tissue is depleted dur-
ng tumor growth (Wood et al., 1974). The consequent
changes taking place in the liver may represent an inter-
mediate transport mechanism by which the fatty acids are
efficiently furnished to the neoplastic cells. These fatty
acids could consist of the essential fatty acids necessary
for membrane formation and cell growth as well as a gen-
eral mixture of the usual 16-and 18- carbon acids for ener-
gy. Since fatty acids for these purposes may be derived
from the diet, synthesized in other tissues, or released
from stored trigylcerides, it has not been easy to predict
in many cases, or to interpret the changes in the fatty
acids themselves, particularly since some of the enzymes
involved in fatty acids alteration are missing or have
escaped control in the tumor (Chiappe et al., 1974).
However, the changes in the lipids, which must be synthe-
sized in the tissues themselves by known pathways, may
be very revealing.
Nakazawa and Mead (1976) measured the alterations
in liver lipids in female BALB-c nude mice bearing trans-
planted cells from a human ovarian adenocarcinoma and
reported significant changes in the phospholipidrtriglyc-
eride (PL:TL) ratio brought about by increases in the
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>hospholipid fraction and decreases in the triglyceride
raction. This system was proposed as a model for study-
ng similar changes seen in the liver lipids of human
>atients (Nakazawa and Yamagata, 1971). However, in
lese earlier experiments, the degree of tumor metastatic
jrade, as well as the cell numbers implanted in the mice
were not characterized and quantified. Such lack of pre-
ise number of the implanted cells as well as varying
egree of grades of the tumor metastasis level might have
>een the cause for the disparities seen in different studies
one using freshly obtained human tissues as the source
fcells to implant into mice.
Iln order to obviate some of the problems and gainirther information on the mechanisms producing liverlanges, the present study was done using an establishedonal cell line derived from a human metastatic prostate•ade IVadenocarcinoma. This permitted a more quanti-tive injection and, inaddition, treatment of some of the:11s byglutaraldehyde.
Materials and Methods
Chloroform, methanol, petroleum ether, and pentane
were reagent grade and were distilled before use. Ethyl
ther was used directly from a freshly opened can of
eagent grade ether. Other reagents were also reagent
jrade. Standards for gas-liquid chromatography were
btained from NU-Chek Prep, Elysian, Minnesota and
Applied Science Laboratory (State College, Pennsylvania).
I
Treatment of Animals.
—
Male BALB-c nude mice 19
eeks old were divided into three groups and treated as
dlows. Four control mice (group 1) were not injected. In
¦oup 2 four experimental mice were injected subcuta-
sously on the right side with 0.2 ml (4 by 106 cells) of
:11s from cell line PC3, a human metastatic prostate
•ade IVcarcinoma, cloned and cultured inF12 plus 7.5%
Drse serum and 25% fetal calf serum. Four mice, making
oup 3, were injected with the same type of cells but
hich had been fixed for one hour with 2.5% glutaralde-
in 0.1 Msodium cacodylate pH 7.4 buffer and
used 20 hr. in0.1 M sodium phosphate buffer, pH 7.4.
tie injected and the control mice were kept for 18 days
;fore sacrifice by cervical dislocation. The livers were
moved and frozen at -80°C untilextraction.
IExtraction and Analysis ofLipids.
—Lipids were extract-
lfrom liver tissue with chloroform:methanol (2:1) and,
ter washing, the solvent was removed in a stream of
trogen at less than 40°C. The total lipids ineach sample
:re separated into non-polar and polar fractions by elu-
:>n from small silicic acid columns with chloroform and
ethanol, respectively.
1Portions of neutral fractions were separated into com-nents on thin-layer plates (silica gel GD. Merck,
Darmstadt). The thin layer plates were developed using a
mixture of solvents composed of ethyl ether (redistilled
and collected between 60-70 °C), petroleum ether, acetic
acid (20:80:1), or chloroform. The developed plates were
sprayed with cupric acetate-phosphoric acid reagent and
charred in an oven at 140°C (Fewster et al., 1969). The
relative proportions of the separated components were
measured using a Kontes densitometer (K-495000 con-
nected to K-495150 integrator), and quantified using
comparison with standards spotted on the same plates.
Analysis of Component Fatty Acids.
—
Aliquots of lipid
samples were converted into methyl esters by methanoly-
sis, using 5% methanolic HCL. The methyl esters of the
component fatty acids were separated and quantified on a
Beckman gas chromatograph (6C-M) fitted with disc inte-
grator and using a 6' x 3/8" column of siliac IOC. The
chromatograph was operated at 185 °C. Areas under the
peaks were read from the integrator.
Table 1. Distribution of lipids in livers of control and
injected mice.
Treatment ofMice
Group 1 Group 2 Group 3
Uninjected Viable Growing Glutaraldehyde Fixed
Controls Cells Injected Cells Injected
Total Liver Lipida 23.2±0.16 23.2±0.04 19.7±0.05
Percent ofPolar Lipids 70 ±4.4 78 ±2.3* 77 ±2.5*
Percent ofNeutral Lipids 32 ±2.1 21 ±2.1* 22 ±1
Triglyceride b 69 ±2.9 71 ±12.5 65.4±4.4
Total Cholesterol 31 ±3.3 28 ±18.2 35 ±4.1
Ratio: 2.2±0.2 3.6±0.09* 3.5±0.26'
Polar Lipid/Neutral Lipid
(4)c (4)c (4)C
Allstatistical comparisons were done using student's test.
aValues are of mean +S.D. ofmg per g wet wtoflivers,
expressed as percent ofneutral lipids.
cNumber ofmice in each group. The liver from each mouse was separately
analyzed.
? Significantly different from controls at the 0.01 level.
Results
Distribution ofLipids.
—
The state of the injected cells
did not change the total percentage of lipids profiles in
the livers of mice (Table 1). However, there was a signifi-
cantly higher proportion of polar lipid and a lower pro-
portion of neutral lipid within the TLLin the mice inject-
ed with any of the cell preparations. This is reflected in a
highly significant difference in the ratios of polar to neu-
tral lipids between the controls and all treated groups.
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Moreover, there were no significant differences in these
values among the treated groups (Table 2).
Within the neutral lipid fractions, there was consider-
able variation in the proportions of triglycerides and total
cholesterol as reflected in the standard deviations. This
variability was also apparent in the distribution of free
and esterified cholesterol. The meaning of these changes
is not apparent. Among the fatty acids, there were no sig-
nificant differences attributed to the treatment of the
mice though the usual differences (Table 2) in neutral
and polar lipids were seen.
Table 2. Distribution of major fatty acids in polar and
neutral lipids of control and injected mice (mean of rela-
tive percentages + SD)
A.Polar Lipids 16:0 16:1 18:0 18:1 18:2 20:4 22:6
Group I(4)
Uninjected Control 22.8+4.6 1.03+0.7 18.6±1 11.6±0.95 20.6±5.01 17.2+0.24 4.8±0.81
Group 2 (4)
Viable Cells
Injected 27.9+4.5 0.25±1.0 12.0±7.8 14.9+4.04 18.4±6.02 18.8±1.82 4.0±1.75
Group 3 (4)
jlutaraldehyde
Fixed Cells Injected 25.3±3.7 0.2±0.02 21.1±0.07 12.3±1.3 16.0±1.05 20.4±1.35 3.3±2.25
B.Neutral Lipids
Group 1(4)
Uninjected Control 30.9±2.88 2.03±1.25 3.08±0.43 39.4±4.57 16.88±2.13 1.2±0.78 0
Group 2 (4)
Viable Growing
Cell Injected 35.88±6.74 1.83±1.94 3.85±0.94 32.38±4.92 16.53±4.92 2.35±0.41 0
Group 3 (4)
Glutaraldehyde
Fixed Cell Injected 32.1+1.85 1.5+1.66 2.65+0.35 33.65+1. 35 22.65+4.65 1.5+0.5 0
"he number inparentheses is the number ofmice receiving each treatment. Each liver
was separately analyzed.
Discussion
The results of these experiments appear to confirm
hose of Nakazawa and Mead (1976) since there is an
ncrease in the ratio of polar lipid to neutral lipidin mice
njected with the neoplastic cells. They do not however,
onfirm the very large difference between control and
xperimental values shown in the prior study.
Explanations for these differences are not difficult to sug-
jest. First, whole tissue from an ovarian adenocarcinoma
was injected in the earlier study, while known numbers of
ells from an established line derived from a metastatic
>rostate adenocarcinoma were used in the present study
with male mice. Second, two months elapsed between
njection and sacrifice in the prior experiment, thus allow-
ing for considerable cell proliferation. Third, male ani-
mals were used in the present study while females were
used in the previous one. In the present study, only two
weeks elapsed between injection and sacrifice with the
hope that changes occurring before profound generalized
metabolic changes occurred could be seen. Moreover,
since numbers of cells were not known in the previous
work, an attempt was made in the present study to com-
pensate for the proliferation of the viable injected cells by
injecting larger numbers of the non-growing cells.
Whether for this or other reasons, no significant differ-
ences in total liver lipids were seen between the livers of
mice injected with proliferating cells and uninjected con-
trols. However, there was a significant decrease of total
liver lipids in the livers of mice injected with non-prolifer-
ating cells. But, when the total liver lipids from each
group were fractionated into polar and non-polar compo-
nents and each component expressed as a percent of the
total liver lipids for each experimental group, there was
no significant difference between the percentages in the
two groups injected with cells (Table 1). The observed
changes, therefore, cannot be a result ofrapid growth of
the injected neoplastic cells, but must depend on some
other unknown cause. Such a cause might be attributed
to the reactions of the injected cells with the host animal
immune response. The reaction may be to increase the
availability to the foreign cells of fatty acids needed for
growth and energy demands. In the present case howev-
er, only in one of the groups were the foreign cells able to
utilize the fatty acids. With the possible exception of 18:1
and 16:1 (Table 2) the lack of significant change in the
fatty acids of neutral and polar lipids may indicate that
there was no selective use of theses as opposed to utiliza-
tion of the entire complement of the lipidinvolved.
Kampschmidt and Upchurch (1966) have called atten-
tion to the fact that the site of tumor transplant in an ani-
mal may lead to variation in the results obtained. We do
not know whether this is also true as far as lipids are con-
cerned. Total cholesterol in the control mice was con-
stant, whereas in the mice bearing cells, there were some
fluctuations as reflected in the large standard deviations
(Table 2) with most variations in the mice injected with
viable cells. Failure to find a substantial decrease of
triglycerides in the lipids of mice injected with viable cells
does not seem to support the notion frequently cited that
the decrease is due to the presence of a tumor (Stein et
al., 1965; Stein et al., 1966). These animals did not show
any gross pattern of lipid loss. Itwas not possible to tell
the experimental from the control mice in this respect.
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